As a principal scientist at Janssen, Mark Tichenor’s main responsibility is to identify new drug targets for immunology diseases. But it takes more than a team of medicinal chemists to figure out the types of medicines that can best treat patients with these diseases. In this interview, Tichenor shares his excitement about the opportunity to collaborate with other scientists and discusses the importance of alumni network for undergraduate students.
Want more stories like this delivered to your inbox?
Sign up for our newsletter to receive a selection of stories related to your favorite topics.